KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Invested Capital (2018 - 2025)

Historic Invested Capital for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $15.9 million.

  • ClearPoint Neuro's Invested Capital fell 4526.4% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 4526.4%. This contributed to the annual value of $25.4 million for FY2024, which is 1855.45% down from last year.
  • ClearPoint Neuro's Invested Capital amounted to $15.9 million in Q3 2025, which was down 4526.4% from $19.7 million recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Invested Capital ranged from a high of $58.6 million in Q4 2021 and a low of $15.9 million during Q3 2025
  • Its 5-year average for Invested Capital is $38.7 million, with a median of $42.3 million in 2023.
  • Per our database at Business Quant, ClearPoint Neuro's Invested Capital soared by 283248.61% in 2021 and then plummeted by 5513.38% in 2025.
  • ClearPoint Neuro's Invested Capital (Quarter) stood at $58.6 million in 2021, then fell by 20.2% to $46.8 million in 2022, then plummeted by 33.36% to $31.2 million in 2023, then dropped by 18.55% to $25.4 million in 2024, then crashed by 37.48% to $15.9 million in 2025.
  • Its Invested Capital stands at $15.9 million for Q3 2025, versus $19.7 million for Q2 2025 and $20.0 million for Q1 2025.